Aurora A.
- Country
- Portugal
- Department
- N/A
Research Overview
- Phase 3 Randomized Study Comparing Asundexian and Apixaban for Stroke Prevention in Atrial Fibrillation Patients at Risk
- Comparative Phase III Trial of Ferric Derisomaltose Versus No Intravenous Iron in Iron-Deficient Patients with Symptomatic Chronic Heart Failure
- HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation
Data & Insights
Has run more than one trial at 239 of 771 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the field of stroke prevention and cardiac arrhythmia management, with particular emphasis on patients with atrial fibrillation.
- Stroke Prevention Strategies
- Atrial Fibrillation Management
- Systemic Embolism Prevention
Their research focuses on advancing therapeutic approaches for preventing cardiovascular complications in high-risk patients.
Thrombosis Research
The investigator concentrates on antithrombotic therapies and their application in preventing thromboembolic events in cardiovascular conditions.
- Anticoagulation Therapy
- Bleeding Risk Assessment
- Thromboembolism Prevention
Their work encompasses the evaluation of novel therapeutic agents for thrombosis prevention in cardiac patients.
Clinical Therapeutics
The investigator explores comparative therapeutic approaches in cardiovascular medicine, focusing on the effectiveness and safety of different treatment options.
- Novel Therapeutic Agents
- Treatment Safety Profiles
- Clinical Outcomes Assessment
Their expertise extends to evaluating therapeutic interventions for cardiovascular risk management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.